期刊文献+

病毒性乙型肝炎患者血清中补体C_3、转铁蛋白、α_1-抗胰蛋白酶的检测及意义 被引量:5

Detection and clinical significance of C_3、Tf、α_1-AT in serum of patients with hepatitis B.
下载PDF
导出
摘要 探讨乙肝患者血清中补体C3(C3)、转铁蛋白(Tf)、α1-抗胰蛋白酶(α1-AT)含量的变化与肝脏损伤之间的关系。将患者分为急肝组(AH)、慢肝组(CH)、肝硬化组(LC)和肝癌组(HCC)。用速率散射比浊法检测。其结果为:C3各肝病组的含量与对照组相比都下降(P<0.05);AH组、CH组和HCC组均高于LC组,差异有显著性(P<0.01),Tf:各肝病组的含量与对照组相比都下降,差异有显著性(P<0.01)。AH组和CH组分别高于LC组、HCC组,差异有显著性。(P<0.01)α1-AT:AH组和HCC组高于对照组(P<0.01);HCC组高于CH组(P<0.05),差异有显著性。检测乙型肝炎患者血清中的C3、Tf、α1-AT含量,对监测患者肝脏损伤的程度和肝炎的进程有一定的参考意义。 To study the relation between the change of concentration of complement 3 (C3) ,transferrin (Tf) and α1 - antitrypsin (α1 -AT) in sera of patients with hepatitis B and the damage of liver, healthy adults are used as controls. Patients with hepatitis B are divided into four groups : Actue hepatitis ( all), chronic hepatitis ( CH), liver cirrhosis (LC) and liver cancer(HCC). Detect the concentration by ratenephelometer. Results C3 : All groups of hepatitis B are lower than the control group. AH,CH and HCC are higher than LC(P 〈0. 01 ), The differences are significant. Tf: All the groups of hepatitis B are lower than the control group, the differences are significant (P 〈0. 01 ). AH and CH are higher than LC or HCC, The differences are significant. (P〈0. 01 ) α1- AT: AH and HCC are higher than control (P 〈0. 01 ) ;HCC is higher than CH. ( P 〈 0.05 ) ; The differences are significant. There is a significance to observe the degree of the damage of liver and the course of hepatitis detecting the concentration of C3 ,Tf and α1 - AT in sera of patients with hepatitis B.
出处 《临床肝胆病杂志》 CAS 2006年第2期99-100,共2页 Journal of Clinical Hepatology
关键词 乙型肝炎 补体C3 转铁蛋白 Α1-抗胰蛋白酶 hepatitis B complement3 transferrin α1- antitrypsin
  • 相关文献

参考文献5

二级参考文献13

  • 1高艳琴,汪乃经.用建立的BA-ELISA检测尿毒症患者血清转铁蛋白的含量[J].上海医科大学学报,1993,20(2):117-121. 被引量:2
  • 2高艳琴,吕屏,汪迺经,胡锡琪.慢性肝炎患儿血清转铁蛋白含量变化与肝细胞损害程度的关系[J].上海医科大学学报,1995,22(4):268-271. 被引量:5
  • 3吴建文.α1-抗胰蛋白酶及其与原发性肝癌的关系[J].国外医学:消化系疾病分册,1987,7(1):22-22. 被引量:1
  • 4屠振兴.血清α1-抗胰蛋白酶对原发性肝癌诊断价值的探讨[J].上海医学,1985,8(6):357-357. 被引量:1
  • 5李元斋 王玲珍 等.转铁蛋白治疗慢性重症肝炎三例报告[J].中华传染病杂志,1983,1(1):56-57. 被引量:1
  • 6Iancu TC, Deugnier Y, Halliday JW, et al. Morphlogic characteristics of HBV markers and products of iron metabolism in liver tissue inpatients with hepatitis B virus[J]. Vojnosanit pregl, 1992,49(3):477 被引量:1
  • 7Ishida M, Nakagawara G, Imanura Y, et al. Iron and copper deposition in chronic active hepatitis and liver cirrhosis: pathogenetic role in progressive liver cell danage[J] .Eur J Histochem, 1995,39(3):221 被引量:1
  • 8Cable EE,Connor JR, Ison, et al.Accumulation of iron by primary rat hepatocytes in long-term culture: changes in nuclear shape mediatedby no-transferrin-bound forms of iron[J]. Am J Pathol, 1998,152(3): 781. 被引量:1
  • 9Akiyoshi F, Stata M, Uchimura Y, et al. Hepatic iron staings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy[J] .Am J Gastroenterol, 1997,92(9): 1463 被引量:1
  • 10Olynyk JK, Reddy KR, Di-Bisceglie AM, et al. Hepatic iron concentration as a predictor to interferon alfa therapy in chronic hepatitis C[J]. Gastroenterology, 1995,108(4): 1104 被引量:1

共引文献35

同被引文献31

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部